[1] |
JIANG Lu, ZHANG Zhidong, WU Jianjun, LIU Lu, SHANG Longjian, WEI Xingmin .
Changing trends in the disease burden of liver cancer in China and the United States from 1990 to 2021 and its predictions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 55-60.
|
[2] |
PAN Hongxin, CUI Wangfei, LYU Licheng, WANG Xinzheng, CAO Ling, ZHANG Yongzhen.
Analysis of the incidence and mortality of malignant tumors in tumor registration areas of Shanxi Province,2020
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 700-706.
|
[3] |
WANG Xingchen, LIAO Dawen, LI Jiaying, SUN Xiacheng, BI Qian, Huang Qichao, HUANG Jiangtao.
Comparative analysis of molecular characteristics of constitutive activation of NRAS and CTNNB1 in liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 577-585.
|
[4] |
DONG Junling, YANG Hui, LI Na.
Trend of the incidence of gastric cancer in China,1992—2021
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 593-597.
|
[5] |
LU Feichen, YOU Xuemei, ZHAO Fengjuan, LI Fanrong, WEI Shuangshuang, YANG Lijie.
Investigation on the status quo of the quality of life in patients with intermediate and advanced liver cancer treated by immunotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 468-473.
|
[6] |
SU Lili, LAN Zhenyu, LIN Huizhe, YAN Fangna, CHEN Weilian, LIN Wei.
Effects of sarcopenia on prognosis of prostate cancer treatment: a Meta-analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 487-493.
|
[7] |
LI Huadao, LIN Liqiao, LIANG Yubing, HUANG Enhao, PAN Linghui.
Effects of Herba Houttuyniae on the biological behavior of liver cancer cells and a network pharmacology analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 277-284.
|
[8] |
SUN Xiaoxia, WANG Yuping, SI Meili, ZHU Jing, ZHONG Mei.
Trends of incidence and mortality and the age-period-cohort of cervical cancer in China,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 317-320.
|
[9] |
YUAN Bin, HUANG Delun, ZHOU Fengling, YE Yixian, ZHOU Xiaoqi, WEI Yanfei .
Inhibitory effect of oleanolic acid on liver cancer HCCLM3 cells transplanted tumor in nude mice and its mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 166-171.
|
[10] |
QIN Liming, ZHOU Zihan, CAO Ji, LI Qiulin, YU Jiahua, RONG Minhua, ZHAO Libin, MAI Yuejiao, GE Lianying, QIN Yuzhou, YU Hongping.
Epidemiological characteristics and disease burden analysis of gastric cancer in Guangxi,2011—2018
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 172-178.
|
[11] |
WANG Juwei, WANG Jing, MA Lijun, LI Zan .
Trends in the incidence and mortality of liver cancer in China based on the JoinPoint regression model,2000—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 180-185.
|
[12] |
HE Ziyun, WANG Haolun, FAN Qianqing, LIU Zhihui .
Effects of manganese ion on proliferation and apoptosis of liver cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 62-66.
|
[13] |
ZHOU Zihan, LI Qiulin, YU Jiahua, RONG Minhua, CAO Ji, GE Lianying, TANG Weizhong, YU Hongping.
Analysis of the epidemiological characteristics and disease burden of malignant tumors in Guangxi, 2019#br#
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 67-.
|
[14] |
HUANG Hao, LIANG Jingjing, TAO Yifeng, PAN Xiaolan, FANG Min.
Analysis of hepatitis B virus serum markers in 92,031 cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 101-106.
|
[15] |
DONG Jiaqi, FANG Tao, OU Yong, WEI Jingyi, HU Longquan, LI Yuanyuan, CHAO Xu.
Vitexicarpin inhibits the proliferation of liver cancer cells by regulating glucose metabolism reprogramming
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 615-622.
|